The Terrible—and Amazing—Side Effects of Weight Loss Drugs
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now. GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide),
How easy is it to get weight loss drugs?
It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are now taking either Mounjaro or Wegovy, with experts predicting a nationwide fall in obesity rates.
Some GLP-1s Achieve More Weight Loss Than Others: Study
However, a third drug also FDA-approved for weight loss, liraglutide (Saxenda), didn’t work as well as the others, researchers found after reviewing data from dozens of clinical trials. The review also found that a GLP-1 drug still in development,
Weight Loss Injections May Lower The Risk Of 42 Health Conditions, Including Dementia – Study
Recent research reveals that weight-loss injections reduce the risk of 42 health conditions in people with diabetes, potentially paving the way for broader treatments.
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn't be overlooked,
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
28 benefits, 16 risks: How popular GLP-1 weight loss drugs reshape human health – for better and worse
A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health benefits, from reducing addiction risk to protecting against Alzheimer’s disease.
Researchers reveal benefits, risks linked to popular weight-loss drugs
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity. Commonly marketed under brand names like Ozempic and Wegovy,
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs.
‘Hundreds in hospital with serious reaction to fat loss jabs’ as half a million Brits using injections to shed pounds’
EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...
Katie Price breaks silence over ‘weight loss jabs’ after fans fear for skinny star
KATIE Price has opened up about her weight loss and insists she’s at her “natural weight” after gaining it on IVF. The star ...
New State Treasurer Brad Briner on Wegovy coverage, premium hikes and NC pension fund
Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...
Fat jabs see hundreds in hospital with bad reactions as demand surges
Figures from the Medicines and Healthcare products Regulatory Agency show that increasing numbers need medical treatment ...
Black-market weight drugs put hundreds in hospital with diarrhoea and vomiting
Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...